Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check7 days agoChange DetectedA new revision label (v3.3.3) appears and the HHS Vulnerability Disclosure link was removed from the footer, with no core study data or content changed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe latest version adds the Contacts/Locations and Study Status sections to the Record History for NCT04008121 (version 17).SummaryDifference0.5%

- Check36 days agoChange DetectedThe record history was updated with new sections for Recruiting, Contacts/Locations, Oversight, Study Status, and Recruitment Status (Revision: 3.3.2, dated 2025-11-19). The prior 'Not yet recruiting' status was removed (Revision: 3.2.0, dated 2025-07-02).SummaryDifference0.9%

- Check43 days agoChange DetectedDeletion of the general government funding and operating status notice from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check57 days agoChange DetectedNo substantive changes were observed; the two screenshots show the same record with only minor layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.